BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11751452)

  • 1. Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles.
    Ingelman-Sundberg M; Oscarson M; Daly AK; Garte S; Nebert DW
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1307-8. PubMed ID: 11751452
    [No Abstract]   [Full Text] [Related]  

  • 2. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives.
    Sim SC; Ingelman-Sundberg M
    Methods Mol Biol; 2006; 320():183-91. PubMed ID: 16719391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic gene allele nomenclature.
    Garte S; Boffetta P; Caporaso N; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1305-6. PubMed ID: 11751451
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
    Sim SC; Ingelman-Sundberg M
    Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk.
    Nebert DW
    Cancer Cells; 1991 Mar; 3(3):93-6. PubMed ID: 2054261
    [No Abstract]   [Full Text] [Related]  

  • 6. A nomenclature system for metabolic gene polymorphisms.
    Garte S; Crosti F
    IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2009 Aug; 27(158):166-9. PubMed ID: 19856888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles.
    Ingelman-Sundberg M; Daly AK; Oscarson M; Nebert DW
    Pharmacogenetics; 2000 Feb; 10(1):91-3. PubMed ID: 10739177
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
    Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
    Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
    Tai J; Yang M; Ni X; Yu D; Fang J; Tan W; Huang Z; Wu C; Chen X; Wang G; Zhou W; Chen X; Zhang W; Ma L; Lin D; Han D
    Cancer Genet Cytogenet; 2010 Jan; 196(1):76-82. PubMed ID: 19963139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tricky route from fins to legs for CYP nomenclature.
    Edwards RJ
    Hum Exp Toxicol; 1995 Oct; 14(10):853-4. PubMed ID: 8562128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to hepatocellular carcinoma].
    Ye XP; Peng T; Li LQ
    Wei Sheng Yan Jiu; 2006 Nov; 35(6):805-7. PubMed ID: 17290773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
    Cheng SL; Yu CJ; Yang PC
    Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic polymorphism and risk of diseases induced by chemicals].
    Zhang Z; Xia Z
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):402-5. PubMed ID: 14535113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 nomenclature, 2004.
    Nelson DR
    Methods Mol Biol; 2006; 320():1-10. PubMed ID: 16719369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
    Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
    Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.
    Sim SC; Ingelman-Sundberg M
    Hum Genomics; 2010 Apr; 4(4):278-81. PubMed ID: 20511141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic variations in the metabolism of environmental toxins].
    Autrup H
    Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.